193 related articles for article (PubMed ID: 28738012)
1. Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of cats.
Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K
Am J Vet Res; 2017 Aug; 78(8):946-953. PubMed ID: 28738012
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck Cancer.
Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K
Hum Gene Ther Clin Dev; 2017 Jun; 28(2):80-86. PubMed ID: 28335614
[TBL] [Abstract][Full Text] [Related]
3. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
Bollacke A; Nienberg C; Borgne ML; Jose J
J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
[TBL] [Abstract][Full Text] [Related]
4. Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells.
Kreutzer JN; Ruzzene M; Guerra B
BMC Cancer; 2010 Aug; 10():440. PubMed ID: 20718998
[TBL] [Abstract][Full Text] [Related]
5. 5-lipoxygenase expression and tepoxalin-induced cell death in squamous cell carcinomas in cats.
Wakshlag JJ; Peters-Kennedy J; Bushey JJ; Loftus JP
Am J Vet Res; 2011 Oct; 72(10):1369-77. PubMed ID: 21962280
[TBL] [Abstract][Full Text] [Related]
6. CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.
Brown MS; Diallo OT; Hu M; Ehsanian R; Yang X; Arun P; Lu H; Korman V; Unger G; Ahmed K; Van Waes C; Chen Z
Clin Cancer Res; 2010 Apr; 16(8):2295-307. PubMed ID: 20371694
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.
Trembley JH; Unger GM; Tobolt DK; Korman VL; Wang G; Ahmad KA; Slaton JW; Kren BT; Ahmed K
Mol Cell Biochem; 2011 Oct; 356(1-2):21-35. PubMed ID: 21761204
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of CK2 induces apoptosis in cancer cells--a potential approach to cancer therapy.
Wang G; Unger G; Ahmad KA; Slaton JW; Ahmed K
Mol Cell Biochem; 2005 Jun; 274(1-2):77-84. PubMed ID: 16342410
[TBL] [Abstract][Full Text] [Related]
9. NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.
Li X; Guan B; Maghami S; Bieberich CJ
Mol Cell Biol; 2006 Apr; 26(8):3008-17. PubMed ID: 16581776
[TBL] [Abstract][Full Text] [Related]
10. A N-terminally deleted form of the CK2α' catalytic subunit is sufficient to support cell viability.
Borgo C; D'Amore C; Cesaro L; Itami K; Hirota T; Salvi M; Pinna LA
Biochem Biophys Res Commun; 2020 Oct; 531(3):409-415. PubMed ID: 32800562
[TBL] [Abstract][Full Text] [Related]
11. Inducible expression of protein kinase CK2 in mammalian cells. Evidence for functional specialization of CK2 isoforms.
Vilk G; Saulnier RB; St Pierre R; Litchfield DW
J Biol Chem; 1999 May; 274(20):14406-14. PubMed ID: 10318865
[TBL] [Abstract][Full Text] [Related]
12. Differential localization of alpha' and beta subunits of protein kinase CK2 during rat spermatogenesis.
Alvarado-Díaz CP; Tapia JC; Antonelli M; Moreno RD
Cell Tissue Res; 2009 Oct; 338(1):139-49. PubMed ID: 19711102
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a novel testis-specific gene CKT2, which encodes a substrate for protein kinase CK2.
Bai X; Silvius D; Chan ED; Escalier D; Xu SX
Nucleic Acids Res; 2009 May; 37(8):2699-711. PubMed ID: 19273531
[TBL] [Abstract][Full Text] [Related]
14. Selected flavonoid compounds as promising inhibitors of protein kinase CK2α and CK2α', the catalytic subunits of CK2.
Baier A; Galicka A; Nazaruk J; Szyszka R
Phytochemistry; 2017 Apr; 136():39-45. PubMed ID: 28043654
[TBL] [Abstract][Full Text] [Related]
15. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
16. Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners.
Litchfield DW; Bosc DG; Canton DA; Saulnier RB; Vilk G; Zhang C
Mol Cell Biochem; 2001 Nov; 227(1-2):21-9. PubMed ID: 11827170
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
18. Molecular Plasticity of Crystalline CK2α' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity.
Lindenblatt D; Applegate V; Nickelsen A; Klußmann M; Neundorf I; Götz C; Jose J; Niefind K
J Med Chem; 2022 Jan; 65(2):1302-1312. PubMed ID: 34323071
[TBL] [Abstract][Full Text] [Related]
19. Expression and regulation of protein kinase CK2 during the cell cycle.
Bosc DG; Lüscher B; Litchfield DW
Mol Cell Biochem; 1999 Jan; 191(1-2):213-22. PubMed ID: 10094411
[TBL] [Abstract][Full Text] [Related]
20. Up-Regulation of the Alpha Prime Subunit of Protein Kinase CK2 as a Marker of Fast Proliferation in GL261 Cultured Cells.
Villamañan L; Alcaraz E; Pinna LA; Ruzzene M; Itarte E; Arús C; Plana M; Candiota AP
Pathol Oncol Res; 2019 Oct; 25(4):1659-1663. PubMed ID: 30607803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
